Sec Form 13G Filing - Providence VII U.S. Holdings L.P. filing for - 2025-11-12

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G


 
Providence VII U.S. Holdings L.P.
 
Signature:/s/ Sarah N. Conde
Name/Title:By: Providence Equity GP VII-A L.P., its general partner; PEP VII-A International Ltd., its general partner; Sarah N. Conde, GC, MD & CCO
Date:11/12/2025
 
Providence Equity GP VII-A L.P.
 
Signature:/s/ Sarah N. Conde
Name/Title:By: PEP VII-A International Ltd., its general partner; Sarah N. Conde, GC, MD & CCO
Date:11/12/2025
 
Providence Butternut Co-Investment L.P.
 
Signature:/s/ Sarah N. Conde
Name/Title:By: Providence Equity GP VII-A L.P., its general partner; PEP VII-A International Ltd., its general partner; Sarah N. Conde, GC, MD & CCO
Date:11/12/2025
 
R. Davis Noell
 
Signature:/s/ R. Davis Noell
Name/Title:R. Davis Noell
Date:11/12/2025
 
J. David Phillips
 
Signature:/s/ J. David Phillips
Name/Title:J. David Phillips
Date:11/12/2025
 
Karim A. Tabet
 
Signature:/s/ Karim A. Tabet
Name/Title:Karim A. Tabet
Date:11/12/2025
 
Andrew A. Tisdale
 
Signature:/s/ Andrew A. Tisdale
Name/Title:Andrew A. Tisdale
Date:11/12/2025
 
Michael J. Dominguez
 
Signature:/s/ Michael J. Dominguez
Name/Title:Michael J. Dominguez
Date:11/12/2025
primary_doc.xml